Ilan Melnick
Psychiatry · Miami, FL
CMS Profile ID: 19568 · NPI: 1427048115
Total Disclosed General Payments
$813,000.13
General-payment records
745
CMS Program Year
2025
Most of this (about 60%) was payments for services other than consulting, including faculty or speaking services outside continuing education.
Payments by Type
| Payment Type | Amount |
|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $487,927.00 |
| Consulting Fee | $130,434.08 |
| Travel and Lodging | $103,492.79 |
| Honoraria | $73,456.50 |
| Food and Beverage | $17,580.27 |
| Education | $109.49 |
Top Paying Companies
| Manufacturer / GPO | Amount |
|---|---|
| Neurocrine BioSciences, Inc. | $160,072.79 |
| E.R. Squibb & Sons, L.L.C. | $141,765.78 |
| Otsuka America Pharmaceutical, Inc. | $139,943.71 |
| Teva Pharmaceuticals USA, Inc. | $119,505.84 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $88,698.88 |
| Axsome Therapeutics, Inc. | $70,830.03 |
Top contributing companies shown; smaller payers may be omitted.
These totals are computed from the official CMS Open Payments program-year 2025 general-payment
file. To see the full, authoritative record for this provider — including research payments and
line-item detail — look them up by exact NPI 1427048115 on the
official CMS Open Payments portal.
Verify this record with CMS
- Confirm the provider's exact NPI: 1427048115.
- Select program year 2025 and general payments in the CMS portal.
- Check individual payment records and their nature-of-payment categories.